Supernus Pharmaceuticals, Inc. (SUPN): Price and Financial Metrics

Supernus Pharmaceuticals, Inc. (SUPN)

Today's Latest Price: $21.83 USD

0.07 (-0.32%)

Updated Nov 14 4:00pm

Add SUPN to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

SUPN Stock Summary

  • Supernus Pharmaceuticals Inc's stock had its IPO on May 1, 2012, making it an older stock than 28.07% of US equities in our set.
  • SUPN's price/sales ratio is 3.65; that's higher than the P/S ratio of 67.15% of US stocks.
  • Revenue growth over the past 12 months for Supernus Pharmaceuticals Inc comes in at 14.02%, a number that bests 69% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to SUPN, based on their financial statements, market capitalization, and price volatility, are SBBP, CRNT, DGII, ENVA, and VRNT.
  • Visit SUPN's SEC page to see the company's official filings. To visit the company's web site, go to
SUPN Daily Price Range
SUPN 52-Week Price Range

SUPN Stock Price Chart More Charts

SUPN Price/Volume Stats

Current price $21.83
Prev. close $21.90
Day low $21.50
Day high $22.03
50-day MA $26.56
200-day MA $32.05
52-week high $49.25
52-week low $19.35
Volume 320,744
Avg. volume 579,173
Dividend yield N/A
Market Cap 1.15B

Supernus Pharmaceuticals, Inc. (SUPN) Company Bio

Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The company was founded in 2005 and is based in Rockville, Maryland.

SUPN Latest News Stream

Event/Time News Detail
Loading, please wait...

SUPN Latest Social Stream

Loading social stream, please wait...

View Full SUPN Social Stream

SUPN Price Returns

1-mo -16.71%
3-mo -19.48%
6-mo -34.35%
1-year -49.30%
3-year -8.66%
5-year 157.73%
YTD -34.29%
2018 -16.64%
2017 57.82%
2016 87.87%
2015 61.93%
2014 10.08%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8431 seconds.